ACUR

Acura Pharmaceuticals, Inc. ACUR

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ACUR FLHLF TNPH KALY CBDX NNRX AZFL MRRCF CNBX GNLKQ
6M -80.00 % -99.50 % 54.17 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % -54.55 % 0.00 %
YTD 150.00 % -99.75 % -28.85 % 4 900.00 % 0.00 % -50.00 % 9 900.00 % -90.00 % -95.00 % -60.00 %
1Y -85.71 % -99.61 % -28.85 % -50.00 % 0.00 % -50.00 % 9 900.00 % -90.00 % -91.67 % -60.00 %
3Y -99.00 % -99.75 % -90.51 % 499 900.00 % -95.00 % -50.00 % -50.00 % 900.00 % -99.98 % -60.00 %
5Y -99.77 % -99.97 % -89.46 % 49 900.00 % -93.47 % -83.33 % -50.00 % -99.75 % -100.00 % -92.00 %
10Y -99.98 % -99.97 % 3 600.00 % 150.00 % -97.78 % -93.75 % -99.90 % -99.90 % -99.99 % -90.00 %
From the beginning -100.00 % -99.97 % -99.61 % -99.83 % -100.00 % -99.96 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend